The monoclonal antibody nirsevimab, known as Beyfortus, has been shown to provide significant protection for young infants against hospitalizations due to respiratory syncytial virus (RSV), according to the findings of the French prospective ENVIE study. The study conducted by Naim Ouldali, MD, PhD, and colleagues at the Robert Debré University Hospital in Paris, France, revealed
0 Comments
The issue of members of Congress trading stocks has been a contentious one, with critics arguing that it gives lawmakers an unfair advantage in the market. A bipartisan group of senators recently introduced a new proposal aimed at banning members of Congress from engaging in stock trading. The proposed reforms would prevent members of Congress,
0 Comments
The manhunt in Hertfordshire is intensifying as police search for 26-year-old Kyle Clifford, the prime suspect in the shocking murder of three women in Bushey. Clifford, originally from Enfield, north London, is believed to have worked as a private security guard. Despite appearing normal to those who knew him, Clifford is now wanted for the
0 Comments
Chinese exchange-traded funds have experienced a remarkable surge in growth over the last five years. According to Morningstar, annual inflows to China ETFs have nearly quintupled over the past three years. The data from the American financial services firm shows that total yearly inflows to Chinese ETFs have skyrocketed from 127.2 billion Chinese yuan in
0 Comments
The combination of liposomal gemcitabine and pembrolizumab has stirred excitement in the medical community for its potential in treating advanced solid tumors. Presented at the recent ASCO meeting, this innovative therapy has shown promise in providing new options for patients facing challenging malignancies. Liposomal gemcitabine offers a novel approach to delivering chemotherapy to tumors. By
0 Comments